Sana Biotechnology SANA Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's other working capital?
- Sana Biotechnology (SANA) reported other working capital of $2.62M in Q1 2026.
- How has Sana Biotechnology's other working capital changed year-over-year?
- Sana Biotechnology's other working capital decreased by 20.1% year-over-year, from $3.27M to $2.62M.
- What is the long-term trend for Sana Biotechnology's other working capital?
- Over 4 years (2021 to 2025), Sana Biotechnology's other working capital has grown at a 37.4% compound annual growth rate (CAGR), from $3.08M to $10.98M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.